Home » Topics » Conferences

Conferences
RSS

McMaster University researchers target potential gene therapies for arthritis

Nov. 13, 1998

Bristol-Myers Squibb initiates phase III HBV clinical trials; phase II data reported

Nov. 13, 1998

SB-205553 used to investigate role of 5-HT2C receptor antagonists in PD therapy

Nov. 13, 1998

Leflunomide reduces symptoms of rheumatoid arthritis, slows disease progression in new studies

Nov. 13, 1998

First clinical results reported for novel gene therapy in coronary artery disease

Nov. 12, 1998

SPBN: a free radical scavenger with potential in pediatric head trauma

Nov. 12, 1998

NK2 antagonist from Zeneca blocks increased pulmonary resistance in guinea pigs

Nov. 12, 1998

New mechanism of action described for immunomodulating agent OM-89

Nov. 12, 1998

ETA antagonist has positive effects on pulmonary vascular resistance in patients with HF

Nov. 12, 1998

KGF-2 shows promise for treating IBD

Nov. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...